Company / Free Cash Flow per Share
Gossamer Bio, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.76
FY2025
5-year range
-$2.54 / -$0.02
FY2021-FY2025
Trend
-4814.7%
vs FY2024
Sector context
#96 of 192
Health Care
What the data says
Free Cash Flow per Share changed -4815% YoY in FY2025, a notable deviation from the 7-year average annual change of -654%.
Based on SEC 10-K filings.
-0.76 in FY2025.
Improved from $-1.04 to $-0.76 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 192 in Health CareTop 50% of 192This company -$0.76 Sector average -$19.84
▼
+96.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 4814.7% year-over-year.
- Ranks #96 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.76 | -4814.7% |
| FY2024 | -$0.02 | +98.5% |
| FY2023 | -$1.04 | +52.9% |
| FY2022 | -$2.22 | +12.9% |
| FY2021 | -$2.54 | +2.0% |
| FY2020 | -$2.60 | +3.8% |
| FY2019 | -$2.70 | +67.8% |
| FY2018 | -$8.38 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026